Details of the Drug Combinations

General Information of This Drug (ID: DM5TVS3)

Drug Name
Vinblastine   DM5TVS3
Synonyms
Nincaluicolflastine; Rozevin; VLB; Vinblastin; Vinblastina; Vinblastinum; Vincaleucoblastin; Vincaleucoblastine; Vincaleukoblastine; Vincoblastine; Vinblastina [DCIT]; VR-8; Vinblastina (TN); Vinblastine (INN); Vinblastine [INN:BAN]; Vinblastinum [INN-Latin]; NDC 0002-1452-01; (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE; (2xi,3beta,4'beta,19xi)-vincaleukoblastine; 1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Advanced cancer 2A00-2F9Z Approved [1]
Anterior urethra cancer N.A. Approved [1]
Extragonadal germ cell tumor N.A. Approved [1]
Gestational trophoblastic neoplasia 2F33-2F76 Approved [1]
Kaposi sarcoma 2B57 Approved [1]
Mycosis fungoides 2B01 Approved [1]
Posterior urethra cancer N.A. Approved [1]
Solid tumour/cancer 2A00-2F9Z Approved [2]
Testicular cancer 2C80 Approved [1]
Testicular germ cell tumor N.A. Approved [1]
Classic Hodgkin lymphoma N.A. Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

516 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Acetazolamide + Vinblastine DCGQGF0 Acetazolamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Acetohydroxamic Acid + Vinblastine DC9CMMR Acetohydroxamic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Aciclovir + Vinblastine DCDNBMK Aciclovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Amodiaquine + Vinblastine DCPSUT4 Amodiaquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Anamorelin + Vinblastine DCO6DG3 Anamorelin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Armodafinil + Vinblastine DCE01KH Armodafinil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
AS-1949490 + Vinblastine DCOMGZN AS-1949490 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Asenapine + Vinblastine DCYDRE9 Asenapine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Bepridil + Vinblastine DCYJ912 Bepridil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Brincidofovir + Vinblastine DC7PBU0 Brincidofovir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
BRL-15572 + Vinblastine DCU74BY BRL-15572 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Carglumic acid + Vinblastine DC5A8BK Carglumic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Chloroquine + Vinblastine DCCWRDG Chloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Clopidogrel + Vinblastine DCHR70S Clopidogrel Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Cycloguanil + Vinblastine DCM7APB Cycloguanil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dactinomycin + Vinblastine DC5YUT8 Dactinomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [4]
Dantrolene + Vinblastine DCWGYS8 Dantrolene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Darunavir + Vinblastine DC2IV2X Darunavir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Desoxycorticosterone pivalate + Vinblastine DC9ST3Z Desoxycorticosterone pivalate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dexmedetomidine + Vinblastine DC34LG7 Dexmedetomidine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dextromethorphan + Vinblastine DCNJX3W Dextromethorphan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dichlorphenamide + Vinblastine DCXLHES Dichlorphenamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dihydroergotamine + Vinblastine DCQAFBU Dihydroergotamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Dopamine + Vinblastine DCF1LY8 Dopamine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Doxapram + Vinblastine DCLDQ0W Doxapram Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Eflornithine + Vinblastine DCUJ0LF Eflornithine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Entacapone + Vinblastine DC8SXAF Entacapone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Epinephrine + Vinblastine DC8680F Epinephrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Eptifibatide + Vinblastine DCCRZYD Eptifibatide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Estramustine + Vinblastine DCNSOS2 Estramustine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ethambutol + Vinblastine DCA5FMQ Ethambutol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ethinyl estradiol + Vinblastine DC9TWI1 Ethinyl estradiol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Etonogestrel + Vinblastine DCTCD96 Etonogestrel Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Everolimus + Vinblastine DCH36Z1 Everolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ezetimibe + Vinblastine DCW8SMG Ezetimibe Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fenoprofen + Vinblastine DCWCXAS Fenoprofen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Flavonoid derivative 1 + Vinblastine DC03X27 Flavonoid derivative 1 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Fluorouracil + Vinblastine DCSYKKN Fluorouracil Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Fluorouracil + Vinblastine DCIVGRH Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Fluorouracil + Vinblastine DC6NZAA Fluorouracil Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Fluorouracil + Vinblastine DCKUELH Fluorouracil Breast carcinoma (Cell Line: KPL1) [5]
Fluorouracil + Vinblastine DCRFSIY Fluorouracil Breast carcinoma (Cell Line: OCUBM) [5]
Fluorouracil + Vinblastine DCDW3EN Fluorouracil Carcinoma (Cell Line: OV90) [5]
Fluorouracil + Vinblastine DCEQ7KQ Fluorouracil Carcinoma (Cell Line: MDAMB436) [5]
Fluorouracil + Vinblastine DCK0IM6 Fluorouracil Colon adenocarcinoma (Cell Line: LOVO) [5]
Fluorouracil + Vinblastine DC3EIVI Fluorouracil Colon carcinoma (Cell Line: RKO) [5]
Fluorouracil + Vinblastine DC5FPC4 Fluorouracil Invasive ductal carcinoma (Cell Line: T-47D) [5]
Fluorouracil + Vinblastine DC66YRL Fluorouracil Rectal adenocarcinoma (Cell Line: SW837) [5]
Fluorouracil + Vinblastine DC5AND3 Fluorouracil Adenocarcinoma (Cell Line: CAOV3) [4]
Fluorouracil + Vinblastine DCFE57P Fluorouracil Adenocarcinoma (Cell Line: OVCAR3) [4]
Fluorouracil + Vinblastine DC56B6L Fluorouracil Adenocarcinoma (Cell Line: A427) [4]
Fluorouracil + Vinblastine DCKN9F4 Fluorouracil Adenocarcinoma (Cell Line: NCIH1650) [4]
Fluorouracil + Vinblastine DCER0C9 Fluorouracil Adenocarcinoma (Cell Line: NCIH2122) [4]
Fluorouracil + Vinblastine DCAXXY6 Fluorouracil Adenocarcinoma (Cell Line: NCIH23) [4]
Fluorouracil + Vinblastine DCV12ZW Fluorouracil Adenocarcinoma (Cell Line: NCIH520) [4]
Fluorouracil + Vinblastine DC09FAG Fluorouracil Adenocarcinoma (Cell Line: COLO320DM) [4]
Fluorouracil + Vinblastine DCAEZL0 Fluorouracil Adenocarcinoma (Cell Line: DLD1) [4]
Fluorouracil + Vinblastine DC4Q2N9 Fluorouracil Adenocarcinoma (Cell Line: HCT116) [4]
Fluorouracil + Vinblastine DCS9C87 Fluorouracil Adenocarcinoma (Cell Line: HT29) [4]
Fluorouracil + Vinblastine DCMAX6Z Fluorouracil Germ cell tumour (Cell Line: PA1) [4]
Fluorouracil + Vinblastine DCI8H2E Fluorouracil Large cell lung carcinoma (Cell Line: NCI-H460) [4]
Fluorouracil + Vinblastine DC9PFU0 Fluorouracil Malignant melanoma (Cell Line: A375) [4]
Fluorouracil + Vinblastine DC9C0EB Fluorouracil Malignant melanoma (Cell Line: HT144) [4]
Fluorouracil + Vinblastine DC77PEW Fluorouracil Malignant melanoma (Cell Line: RPMI7951) [4]
Fluorouracil + Vinblastine DCJ4ACO Fluorouracil Malignant melanoma (Cell Line: SKMEL30) [4]
Fluorouracil + Vinblastine DC5FPIE Fluorouracil Malignant melanoma (Cell Line: UACC62) [4]
Fluorouracil + Vinblastine DC1ZX8G Fluorouracil Mesothelioma (Cell Line: MSTO) [4]
Fluorouracil + Vinblastine DCJ3MOT Fluorouracil Non small cell carcinoma (Cell Line: SKMES1) [4]
Fluorouracil + Vinblastine DCC2I52 Fluorouracil Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [4]
Fluorouracil + Vinblastine DCLH3Q3 Fluorouracil Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [4]
Fluorouracil + Vinblastine DCK9GF9 Fluorouracil Prostate carcinoma (Cell Line: LNCAP) [4]
Fluorouracil + Vinblastine DCMC78C Fluorouracil Prostate carcinoma (Cell Line: VCAP) [4]
FORMESTANE + Vinblastine DCI0E0C FORMESTANE Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
GS4071 + Vinblastine DCP2Z2U GS4071 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
GYKI-52466 + Vinblastine DCMLWPB GYKI-52466 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Hydralazine + Vinblastine DCP166S Hydralazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Hydroxychloroquine + Vinblastine DCMQYQH Hydroxychloroquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Isosorbide dinitrate + Vinblastine DCMO2E8 Isosorbide dinitrate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Levamisole + Vinblastine DCCHZOD Levamisole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Lubiprostone + Vinblastine DCC06SS Lubiprostone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
LY03004 + Vinblastine DCYV06N LY03004 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mefloquine + Vinblastine DCMZVEX Mefloquine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Memantine + Vinblastine DC5W2KF Memantine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mephenytoin + Vinblastine DC0QAY6 Mephenytoin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mesalazine + Vinblastine DCBF4B6 Mesalazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Metaxalone + Vinblastine DCD814W Metaxalone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methocarbamol + Vinblastine DCCUG3X Methocarbamol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methotrexate + Vinblastine DC3VBDK Methotrexate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methoxsalen + Vinblastine DCLXI0L Methoxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Methylergonovine + Vinblastine DCFUQRS Methylergonovine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Miglustat + Vinblastine DC9UL4Q Miglustat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Mycophenolic acid + Vinblastine DCXIG8U Mycophenolic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nabilone + Vinblastine DCJ3FNR Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nitisinone + Vinblastine DCOGCVL Nitisinone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Nitrosoglutathione + Vinblastine DCBSHOD Nitrosoglutathione Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Olmesartan medoxomil + Vinblastine DC8PZ6I Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Oxyphenbutazone + Vinblastine DC4VV35 Oxyphenbutazone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Palonosetron + Vinblastine DCM2J5V Palonosetron Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Paromomycin + Vinblastine DCHMCIJ Paromomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pentostatin + Vinblastine DC44GCX Pentostatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PF-02545920 + Vinblastine DCF990K PF-02545920 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
PFK-158 + Vinblastine DCFP9A0 PFK-158 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Procarbazine + Vinblastine DCI87W6 Procarbazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Pyrazinamide + Vinblastine DCHWJTN Pyrazinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Ramelteon + Vinblastine DCQ42Z7 Ramelteon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Rifampin + Vinblastine DC7U197 Rifampin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Rufinamide + Vinblastine DC38YRV Rufinamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Sertraline + Vinblastine DC6QM5B Sertraline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Sitagliptin + Vinblastine DCZEXHJ Sitagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Spironolactone + Vinblastine DCLZZPZ Spironolactone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Sumatriptan + Vinblastine DCXTOMD Sumatriptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tacrine + Vinblastine DCD1R7P Tacrine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tacrolimus + Vinblastine DCDAU7N Tacrolimus Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tolazoline + Vinblastine DC5EGMJ Tolazoline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tranexamic acid + Vinblastine DCJKK4T Tranexamic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Triapine + Vinblastine DCK8CZG Triapine Chronic myelogenous leukemia (Cell Line: KBM-7) [4]
Triflupromazine + Vinblastine DCPSFI6 Triflupromazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trihexyphenidyl + Vinblastine DCVSJ8Y Trihexyphenidyl Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Triiodothyronine + Vinblastine DCKZ6YX Triiodothyronine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Trimethobenzamide + Vinblastine DCRIB95 Trimethobenzamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Tropisetron + Vinblastine DCN60GR Tropisetron Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Valproic Acid + Vinblastine DCH1PWT Valproic Acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Ribavirin-TP DC0D7EV Ribavirin-TP Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Mebutamate DCGG3V1 Mebutamate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Clindamycin DC7VPAB Clindamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Diethylcarbamazine DC3FVPV Diethylcarbamazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Ruxolitinib DCLW1T3 Ruxolitinib Hodgkin lymphoma (Cell Line: L-1236) [3]
Vinblastine + PD-0325901 DCBESFT PD-0325901 Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + PD-0325901 DC7XOOF PD-0325901 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + PD-0325901 DC2MLE4 PD-0325901 Adenocarcinoma (Cell Line: NCIH1650) [3]
Vinblastine + PD-0325901 DCIR7LK PD-0325901 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + PD-0325901 DCXLDKP PD-0325901 Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + PD-0325901 DC5FHXU PD-0325901 Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + PD-0325901 DCA8F80 PD-0325901 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + PD-0325901 DC14BLX PD-0325901 Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + PD-0325901 DC48269 PD-0325901 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + PD-0325901 DC7DTDF PD-0325901 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + PD-0325901 DCU4JVU PD-0325901 Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + PD-0325901 DCI8O1C PD-0325901 Malignant melanoma (Cell Line: A375) [3]
Vinblastine + PD-0325901 DC2SGMD PD-0325901 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + PD-0325901 DCGJFPT PD-0325901 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + PD-0325901 DC35XVA PD-0325901 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + PD-0325901 DCJ8B3X PD-0325901 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + PD-0325901 DC0HUZ5 PD-0325901 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + PD-0325901 DCRJ392 PD-0325901 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + PD-0325901 DCA1TB8 PD-0325901 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Kanamycin DCDP3MO Kanamycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Triamterene DC0GH52 Triamterene Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Imipramine DC4B1XB Imipramine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Crotamiton DCTSVN0 Crotamiton Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Lapatinib DCLJZO7 Lapatinib Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + Lapatinib DCUE4LH Lapatinib Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + Lapatinib DCKF985 Lapatinib Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + Lapatinib DCWQDGU Lapatinib Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + Lapatinib DC5JFX6 Lapatinib Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + Lapatinib DC9PHQO Lapatinib Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + Lapatinib DCKQTB3 Lapatinib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + Lapatinib DCPIKUP Lapatinib Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + Lapatinib DCVDV8K Lapatinib Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + Lapatinib DCL4NTC Lapatinib Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + Lapatinib DCX5WYO Lapatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + Lapatinib DCYLRUU Lapatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Lapatinib DC4EWUY Lapatinib Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Tindamax DC4J6UV Tindamax Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Furazolidone DC7GR6B Furazolidone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + MK-1775 DCEHULI MK-1775 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + MK-1775 DC08B58 MK-1775 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + MK-1775 DCGGZ6O MK-1775 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + MK-1775 DCYUD0X MK-1775 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + MK-1775 DC5IP4V MK-1775 Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + MK-1775 DCHR8L8 MK-1775 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + MK-1775 DCICDHX MK-1775 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + MK-1775 DCSUA27 MK-1775 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + MK-1775 DCVRA3E MK-1775 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + PMID28460551-Compound-2 DCM80XZ PMID28460551-Compound-2 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + PMID28460551-Compound-2 DCSCOSU PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + PMID28460551-Compound-2 DC3EKY0 PMID28460551-Compound-2 Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + PMID28460551-Compound-2 DCPMKSQ PMID28460551-Compound-2 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + PMID28460551-Compound-2 DCBHRIN PMID28460551-Compound-2 Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + PMID28460551-Compound-2 DCSO9BD PMID28460551-Compound-2 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + PMID28460551-Compound-2 DCO71P8 PMID28460551-Compound-2 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + PMID28460551-Compound-2 DC6A2PQ PMID28460551-Compound-2 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + PMID28460551-Compound-2 DCDGKLO PMID28460551-Compound-2 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + PMID28460551-Compound-2 DCAIM7E PMID28460551-Compound-2 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + PMID28460551-Compound-2 DC753KN PMID28460551-Compound-2 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + PMID28460551-Compound-2 DC3Y084 PMID28460551-Compound-2 Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + PMID28460551-Compound-2 DCTEYFA PMID28460551-Compound-2 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + PMID28460551-Compound-2 DCQD42L PMID28460551-Compound-2 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + PMID28460551-Compound-2 DC2PR2R PMID28460551-Compound-2 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Trioxsalen DCHC4OI Trioxsalen Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Repaglinide DC1DC5D Repaglinide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + RTB101 DCD8YOI RTB101 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + RTB101 DCQRQA1 RTB101 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + RTB101 DCR2765 RTB101 Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + RTB101 DCQV4EK RTB101 Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + RTB101 DCBH7TJ RTB101 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + RTB101 DCT44EB RTB101 Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + RTB101 DCMB3IC RTB101 Adenocarcinoma (Cell Line: HCT116) [3]
Vinblastine + RTB101 DCWR7S4 RTB101 Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + RTB101 DCVRXHH RTB101 Adenocarcinoma (Cell Line: SW-620) [3]
Vinblastine + RTB101 DCI8MJV RTB101 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + RTB101 DCPJJL0 RTB101 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + RTB101 DCQ9HSO RTB101 Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + RTB101 DCB9VNT RTB101 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + RTB101 DCZTZQK RTB101 Malignant melanoma (Cell Line: A375) [3]
Vinblastine + RTB101 DC7870Q RTB101 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + RTB101 DCO8ZXF RTB101 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + RTB101 DC9RKB6 RTB101 Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + RTB101 DCY9CUR RTB101 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + RTB101 DCLG3CI RTB101 Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + RTB101 DCE8GXP RTB101 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + RTB101 DCLR091 RTB101 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + RTB101 DCAVNIA RTB101 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + RTB101 DCU29SX RTB101 Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + SCH-900776 DCXK3ZS SCH-900776 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + SCH-900776 DCZ1N9R SCH-900776 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + SCH-900776 DC5FDW4 SCH-900776 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + SCH-900776 DCKE7MP SCH-900776 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + SCH-900776 DC1DYLJ SCH-900776 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + SCH-900776 DC4EV00 SCH-900776 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Sivelestat DCGRYR0 Sivelestat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Pepstatin DCKU227 Pepstatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Dronedarone DC3XTYE Dronedarone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + SNX-2112 DCVNDIE SNX-2112 Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + SNX-2112 DCF74GB SNX-2112 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + SNX-2112 DCBKDRX SNX-2112 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + SNX-2112 DCMWS0A SNX-2112 Malignant melanoma (Cell Line: A375) [3]
Vinblastine + SNX-2112 DC3I3GE SNX-2112 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + SNX-2112 DC5SQVT SNX-2112 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + SNX-2112 DC4EGHG SNX-2112 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + BHV-0223 DCLD6YY BHV-0223 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Buspirone DCZBZX0 Buspirone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Testosterone cypionate DCS7GXM Testosterone cypionate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + SCH 727965 DCOZYC7 SCH 727965 Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + SCH 727965 DC6V513 SCH 727965 Adenocarcinoma (Cell Line: A427) [3]
Vinblastine + SCH 727965 DC1ZNLD SCH 727965 Adenocarcinoma (Cell Line: NCIH1650) [3]
Vinblastine + SCH 727965 DCNGBKB SCH 727965 Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + SCH 727965 DCB7TCX SCH 727965 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + SCH 727965 DCYQ565 SCH 727965 Adenocarcinoma (Cell Line: HCT116) [3]
Vinblastine + SCH 727965 DC09DPF SCH 727965 Adenocarcinoma (Cell Line: SW-620) [3]
Vinblastine + SCH 727965 DCUPWGZ SCH 727965 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + SCH 727965 DCTKDC7 SCH 727965 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + SCH 727965 DCHQ6F6 SCH 727965 Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + SCH 727965 DCZ30TQ SCH 727965 Malignant melanoma (Cell Line: A375) [3]
Vinblastine + SCH 727965 DCMR7ON SCH 727965 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + SCH 727965 DCWQJJW SCH 727965 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + SCH 727965 DCMKYGK SCH 727965 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + SCH 727965 DCK7232 SCH 727965 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + SCH 727965 DC1UWIK SCH 727965 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Erlotinib DCW2GRA Erlotinib Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + Erlotinib DC7G2ZT Erlotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + Erlotinib DCZBLQV Erlotinib Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + Erlotinib DC5PSCC Erlotinib Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + Erlotinib DCAZPFL Erlotinib Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + Erlotinib DCNCXJ5 Erlotinib Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + Erlotinib DCGYEBI Erlotinib Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + Erlotinib DC20J6W Erlotinib Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + Erlotinib DCF9XRI Erlotinib Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + Erlotinib DCTQ92E Erlotinib Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + Erlotinib DC76Y9J Erlotinib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + Erlotinib DC4FDC7 Erlotinib Malignant melanoma (Cell Line: A375) [3]
Vinblastine + Erlotinib DCHW9OX Erlotinib Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + Erlotinib DCRKMXS Erlotinib Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + Erlotinib DCZQ1GF Erlotinib Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + Erlotinib DC9TKEZ Erlotinib Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + Erlotinib DCYJQ3Q Erlotinib Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + Erlotinib DC1IRZJ Erlotinib Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + Erlotinib DC7G85P Erlotinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + Erlotinib DC1P3J5 Erlotinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Erlotinib DCIVCDH Erlotinib Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + Erlotinib DCMPB62 Erlotinib Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Itraconazole DCN8WJC Itraconazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Emetine DCU6PX0 Emetine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Chlorzoxazone DCEQEMH Chlorzoxazone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Phenprocoumon DC1YFAE Phenprocoumon Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + ETHISTERONE DCLKIA8 ETHISTERONE Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Cilastatin DCLRQFQ Cilastatin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Aminosalicylic acid DCT3L69 Aminosalicylic acid Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Sulfinpyrazone DC4NE6C Sulfinpyrazone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Pazopanib DC0TNYV Pazopanib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Daidzin DCUQHMS Daidzin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + MK-5108 DC032GV MK-5108 Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + MK-5108 DCIO4D9 MK-5108 Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + MK-5108 DCF2ND9 MK-5108 Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + MK-5108 DCBY7IT MK-5108 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + MK-5108 DCY4ST9 MK-5108 Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + MK-5108 DC2PVUP MK-5108 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + MK-5108 DCFO37Z MK-5108 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + MK-5108 DCFA0MZ MK-5108 Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + MK-5108 DC9ZQEP MK-5108 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + MK-5108 DCF6HJP MK-5108 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + MK-5108 DCXOLX5 MK-5108 Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + MK-5108 DC2Z0KZ MK-5108 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + MK-5108 DCZHIW1 MK-5108 Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + MK-5108 DC2USGX MK-5108 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + VR-776 DCR4WMV VR-776 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Nizatidine DCK8IUV Nizatidine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Naringenin DCJAHIB Naringenin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Bosentan DCXLHRT Bosentan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Tolvaptan DCBBVGN Tolvaptan Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Trazodone DCVY65Q Trazodone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Isoproterenol DCXTKO4 Isoproterenol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Trifluoperazine DCVNR53 Trifluoperazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Diazoxide DCSEG6U Diazoxide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Ridaforolimus DCGLAEF Ridaforolimus Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + Ridaforolimus DCYHIWJ Ridaforolimus Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + Ridaforolimus DCGPPW8 Ridaforolimus Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + Ridaforolimus DCPIFLS Ridaforolimus Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + Ridaforolimus DCIUUH7 Ridaforolimus Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + Ridaforolimus DCZ58W3 Ridaforolimus Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + Ridaforolimus DCM6TTJ Ridaforolimus Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + MK-4827 DCR57DF MK-4827 Adenocarcinoma (Cell Line: OVCAR3) [3]
Vinblastine + MK-4827 DC5922K MK-4827 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + MK-4827 DC6P88M MK-4827 Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + MK-4827 DC8HHT6 MK-4827 Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + MK-4827 DC8VAVU MK-4827 Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + MK-4827 DCGO38J MK-4827 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + MK-4827 DCNDRJA MK-4827 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + MK-4827 DC27KSU MK-4827 Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + MK-4827 DCMVI6G MK-4827 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + MK-4827 DC2L8D0 MK-4827 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + MK-4827 DC2MOXN MK-4827 Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + MK-4827 DC3J1UQ MK-4827 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + MK-4827 DCF5FV4 MK-4827 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + MK-4827 DCM4K55 MK-4827 Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + MK-4827 DCS4DWM MK-4827 Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Idarubicin DCTL9LV Idarubicin Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + Idarubicin DCRBTGR Idarubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Idarubicin DCHJ841 Idarubicin Glioblastoma? (Cell Line: T98G) [3]
Vinblastine + Abacavir DCC64U4 Abacavir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Linagliptin DCHIBNC Linagliptin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Pramipexole DCTAJ1U Pramipexole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Bortezomib DCADVMS Bortezomib Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + Bortezomib DCGBQVB Bortezomib Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + Bortezomib DC015V8 Bortezomib Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + Bortezomib DCXRVKB Bortezomib Adenocarcinoma (Cell Line: HT29) [3]
Vinblastine + Bortezomib DC135RB Bortezomib Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + Bortezomib DCA4DKX Bortezomib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + Bortezomib DCTJA8M Bortezomib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + Bortezomib DCJR9F8 Bortezomib Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + Bortezomib DCNNFBA Bortezomib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Ethinyl estradiol DCDFRJK Ethinyl estradiol Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Moricizine DCXWVRA Moricizine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Artemisinin DC8QGRK Artemisinin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Enalaprilat DCEH2WQ Enalaprilat Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Maprotiline DCQ5T34 Maprotiline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Teriflunomide DCVEEEV Teriflunomide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole DCQ6NWU 1-((2-chlorophenyl)diphenylmethyl)-1H-pyrazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Novobiocin DC5EZ5W Novobiocin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Acarbose DCYFRLB Acarbose Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Bumetanide DCVN2HN Bumetanide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Amantadine DCSKNRF Amantadine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Sorafenib DCQJ6UE Sorafenib Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + Sorafenib DC3N6DP Sorafenib Adenocarcinoma (Cell Line: A427) [3]
Vinblastine + Sorafenib DCDS8AV Sorafenib Adenocarcinoma (Cell Line: NCIH2122) [3]
Vinblastine + Sorafenib DC7P7DY Sorafenib Adenocarcinoma (Cell Line: NCIH23) [3]
Vinblastine + Sorafenib DC023Z8 Sorafenib Adenocarcinoma (Cell Line: NCIH520) [3]
Vinblastine + Sorafenib DCVE6UB Sorafenib Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + Sorafenib DCDAOTZ Sorafenib Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + Sorafenib DCXEWDG Sorafenib Adenocarcinoma (Cell Line: HCT116) [3]
Vinblastine + Sorafenib DCH033B Sorafenib Adenocarcinoma (Cell Line: SW-620) [3]
Vinblastine + Sorafenib DCXX7ZN Sorafenib Amelanotic melanoma (Cell Line: A2058) [3]
Vinblastine + Sorafenib DCKKPBC Sorafenib Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Sorafenib DCL5AVV Sorafenib Ewing sarcoma-peripheral primitive neuroectodermal tumour (Cell Line: ES2) [3]
Vinblastine + Sorafenib DCFMFIN Sorafenib Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + Sorafenib DCZMEC9 Sorafenib Malignant melanoma (Cell Line: A375) [3]
Vinblastine + Sorafenib DCBTUV6 Sorafenib Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + Sorafenib DCNWFPX Sorafenib Malignant melanoma (Cell Line: SKMEL30) [3]
Vinblastine + Sorafenib DCGW0W9 Sorafenib Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + Sorafenib DCUIOGM Sorafenib Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + Sorafenib DC1IS6S Sorafenib Non small cell carcinoma (Cell Line: SKMES1) [3]
Vinblastine + Sorafenib DCS903P Sorafenib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + Sorafenib DCI2VFY Sorafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Sorafenib DCJ9AN9 Sorafenib Prostate carcinoma (Cell Line: LNCAP) [3]
Vinblastine + Sorafenib DCLWKZ0 Sorafenib Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Quinine DCD1FRM Quinine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + MK-2206 DC6T62W MK-2206 Adenocarcinoma (Cell Line: CAOV3) [3]
Vinblastine + MK-2206 DCSC8YB MK-2206 Adenocarcinoma (Cell Line: NCIH1650) [3]
Vinblastine + MK-2206 DCS340J MK-2206 Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + MK-2206 DCT9ZXJ MK-2206 Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Vinblastine + MK-2206 DCNHL2T MK-2206 Malignant melanoma (Cell Line: HT144) [3]
Vinblastine + MK-2206 DCZT8V9 MK-2206 Malignant melanoma (Cell Line: RPMI7951) [3]
Vinblastine + MK-2206 DC126J3 MK-2206 Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + MK-2206 DCWW7C9 MK-2206 Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + MK-2206 DCTT4H6 MK-2206 Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + MK-2206 DCSK0UP MK-2206 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Loperamide DCU16PG Loperamide Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Maraviroc DCRJ3WM Maraviroc Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Chlormezanone DCUDH0C Chlormezanone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Cisatracurium DCJMTL3 Cisatracurium Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Fosfomycin DC376GF Fosfomycin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Doxorubicin DC0HPIN Doxorubicin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Iloprost DCE2ZIZ Iloprost Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Nabilone DCH6L4O Nabilone Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Silver sulfadiazine DCKZIUT Silver sulfadiazine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Olmesartan medoxomil DCL136R Olmesartan medoxomil Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Auranofin DC6082E Auranofin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Cevimeline DCWUF4R Cevimeline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + ML323 DCIL6PD ML323 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Enoxacin DCCB2QS Enoxacin Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Raltegravir DCGBFKP Raltegravir Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Albendazole DCIZK5A Albendazole Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + GSK2194069 DC6ZZNT GSK2194069 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Dasatinib DCK80M5 Dasatinib Adenocarcinoma (Cell Line: COLO320DM) [3]
Vinblastine + Dasatinib DCLXJV2 Dasatinib Adenocarcinoma (Cell Line: DLD1) [3]
Vinblastine + Dasatinib DCUYJY2 Dasatinib Germ cell tumour (Cell Line: PA1) [3]
Vinblastine + Dasatinib DCUAMO9 Dasatinib Malignant melanoma (Cell Line: A375) [3]
Vinblastine + Dasatinib DCU06SH Dasatinib Malignant melanoma (Cell Line: UACC62) [3]
Vinblastine + Dasatinib DCKS62T Dasatinib Mesothelioma (Cell Line: MSTO) [3]
Vinblastine + Dasatinib DCNIIED Dasatinib Ovarian endometrioid adenocarcinoma (Cell Line: A2780) [3]
Vinblastine + Dasatinib DCMGHD5 Dasatinib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [3]
Vinblastine + Dasatinib DC71XEL Dasatinib Prostate carcinoma (Cell Line: VCAP) [3]
Vinblastine + Azatadine DC7JSV5 Azatadine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Tetracycline DCL14D5 Tetracycline Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Cytarabine DCTW9IU Cytarabine Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + Etomidate DCAY8UF Etomidate Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
Vinblastine + PD-0325901 DCP8CC7 PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + PD-0325901 DC35LLF PD-0325901 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + PD-0325901 DCNS3VG PD-0325901 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + PD-0325901 DCB3I1Z PD-0325901 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + PD-0325901 DC0S9TM PD-0325901 Carcinoma (Cell Line: OV90) [5]
Vinblastine + PD-0325901 DC6F15U PD-0325901 Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + PD-0325901 DCCP1LE PD-0325901 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + PD-0325901 DC3VU2V PD-0325901 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + Lapatinib DC1H99O Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + Lapatinib DCNYV13 Lapatinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + Lapatinib DC93T4L Lapatinib Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + Lapatinib DC87NOS Lapatinib Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + Lapatinib DCX6XU7 Lapatinib Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + MK-1775 DCIAUA6 MK-1775 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + MK-1775 DCMG4XG MK-1775 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + PMID28460551-Compound-2 DCGOZX7 PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + PMID28460551-Compound-2 DC60FMG PMID28460551-Compound-2 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + PMID28460551-Compound-2 DC6BNJY PMID28460551-Compound-2 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + PMID28460551-Compound-2 DCQZB9M PMID28460551-Compound-2 Carcinoma (Cell Line: OV90) [5]
Vinblastine + PMID28460551-Compound-2 DC5T16C PMID28460551-Compound-2 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + PMID28460551-Compound-2 DCHUWOJ PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + PMID28460551-Compound-2 DCLVZQS PMID28460551-Compound-2 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + RTB101 DCQ722F RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + RTB101 DCOPZRY RTB101 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + RTB101 DCLP3K7 RTB101 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + RTB101 DCPLECM RTB101 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + RTB101 DCWRZ2J RTB101 Carcinoma (Cell Line: OV90) [5]
Vinblastine + RTB101 DCO8N3E RTB101 Carcinoma (Cell Line: EFM192B) [5]
Vinblastine + RTB101 DC2612B RTB101 Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + RTB101 DCY95L2 RTB101 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + RTB101 DCY9A9C RTB101 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + RTB101 DCEMH7E RTB101 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + SCH-900776 DCNGRML SCH-900776 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + SCH-900776 DCT9U5R SCH-900776 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + SCH-900776 DC16DFA SCH-900776 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + SCH-900776 DCK0KWN SCH-900776 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + SNX-2112 DCLM1VT SNX-2112 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + SNX-2112 DCVGN0K SNX-2112 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + SNX-2112 DC6RMHM SNX-2112 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + SNX-2112 DCY3WK0 SNX-2112 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + SCH 727965 DCRN7PM SCH 727965 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + SCH 727965 DC14IKY SCH 727965 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + SCH 727965 DC1RG4A SCH 727965 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + SCH 727965 DCAK97G SCH 727965 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + Erlotinib DC8CMK9 Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + Erlotinib DCI13R3 Erlotinib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + Erlotinib DCDF3KR Erlotinib Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + Erlotinib DCJU62R Erlotinib Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + Erlotinib DCQW2AJ Erlotinib Carcinoma (Cell Line: OV90) [5]
Vinblastine + Erlotinib DC9S1R1 Erlotinib Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + Erlotinib DCU8NRA Erlotinib Colon adenocarcinoma (Cell Line: LOVO) [5]
Vinblastine + Erlotinib DCBRNJ0 Erlotinib Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + Erlotinib DC7EG8P Erlotinib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + Erlotinib DCYKB6V Erlotinib Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + MK-5108 DCZKNMT MK-5108 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + MK-5108 DCG7CLQ MK-5108 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + MK-5108 DCHGFXN MK-5108 Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + MK-5108 DC12X2E MK-5108 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + MK-5108 DCDEM1O MK-5108 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + Ridaforolimus DC96QWW Ridaforolimus Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + Ridaforolimus DCM6OIV Ridaforolimus Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + Ridaforolimus DCEI53K Ridaforolimus Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + Ridaforolimus DCWGPY1 Ridaforolimus Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + MK-4827 DC08GXQ MK-4827 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + MK-4827 DCXTXTJ MK-4827 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + MK-4827 DC2Q86I MK-4827 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + MK-4827 DCD635T MK-4827 Carcinoma (Cell Line: OV90) [5]
Vinblastine + MK-4827 DCF7KOL MK-4827 Carcinoma (Cell Line: EFM192B) [5]
Vinblastine + MK-4827 DCGPVX8 MK-4827 Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + MK-4827 DCVQ6ZG MK-4827 Colon adenocarcinoma (Cell Line: LOVO) [5]
Vinblastine + MK-4827 DCWYHPM MK-4827 Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + MK-4827 DC1M4FQ MK-4827 Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + MK-4827 DCBY76X MK-4827 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + Bortezomib DCWUG6L Bortezomib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + Bortezomib DCA1AB7 Bortezomib Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + Bortezomib DC1YHCD Bortezomib Colon adenocarcinoma (Cell Line: LOVO) [5]
Vinblastine + Bortezomib DCS6EZ3 Bortezomib Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + Bortezomib DCNTM39 Bortezomib Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + GSK525762 DCZSDDS GSK525762 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + GSK525762 DC8LYL2 GSK525762 Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + Sorafenib DC21CRB Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + Sorafenib DCA3BEA Sorafenib Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + Sorafenib DCCGGN5 Sorafenib Breast carcinoma (Cell Line: ZR751) [5]
Vinblastine + Sorafenib DC4DGIL Sorafenib Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + Sorafenib DCKBARM Sorafenib Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + Sorafenib DCKWEQ2 Sorafenib Carcinoma (Cell Line: OV90) [5]
Vinblastine + Sorafenib DCCQ5LR Sorafenib Colon adenocarcinoma (Cell Line: LOVO) [5]
Vinblastine + Sorafenib DC2KHHW Sorafenib Colon carcinoma (Cell Line: RKO) [5]
Vinblastine + Sorafenib DC1MS1D Sorafenib Invasive ductal carcinoma (Cell Line: T-47D) [5]
Vinblastine + Sorafenib DCD7AVE Sorafenib Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + MK-2206 DC19UB9 MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289) [5]
Vinblastine + MK-2206 DCPFRY7 MK-2206 Breast and ovarian cancer syndrome (Cell Line: UWB1289+BRCA1) [5]
Vinblastine + MK-2206 DC1ZDK2 MK-2206 Breast carcinoma (Cell Line: KPL1) [5]
Vinblastine + MK-2206 DCWRJ2G MK-2206 Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + MK-2206 DCNAA3S MK-2206 Rectal adenocarcinoma (Cell Line: SW837) [5]
Vinblastine + Dasatinib DCTZ56Y Dasatinib Breast carcinoma (Cell Line: OCUBM) [5]
Vinblastine + Dasatinib DCXBHET Dasatinib Carcinoma (Cell Line: OV90) [5]
Vinblastine + Dasatinib DCNKI39 Dasatinib Carcinoma (Cell Line: MDAMB436) [5]
Vinblastine + Dasatinib DCDHJ3P Dasatinib Rectal adenocarcinoma (Cell Line: SW837) [5]
WAY-100635 + Vinblastine DC0QM15 WAY-100635 Chronic myelogenous leukemia (Cell Line: KBM-7) [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 516 DrugCom(s)
4 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Methotrexate + Vinblastine DCA6BWO Methotrexate Desmoid Tumor [6]
Methotrexate + Vinblastine DCBGXKZ Methotrexate Neurofibromatosis Type 1 [7]
Vinblastine + Temsirolimus DC4DCA9 Temsirolimus Recurrent Lymphoma [8]
Vinblastine + Nilotinib DCUKT29 Nilotinib Refractory Low-grade Gliomas [9]
------------------------------------------------------------------------------------

References

1 Vinblastine FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6851).
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
5 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
6 ClinicalTrials.gov (NCT00003019) Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
7 ClinicalTrials.gov (NCT00030264) Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
8 ClinicalTrials.gov (NCT02343718) Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
9 ClinicalTrials.gov (NCT01884922) Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults